129 related articles for article (PubMed ID: 38018772)
1. The prognostic value of age-adjusted Charlson comorbidity index in laparoscopic resection for hilar cholangiocarcinoma.
Cai C; Tao L; Li D; Wang L; Xiao E; Luo G; Yan Z; Wang Y; Li D
Scand J Gastroenterol; 2024 Mar; 59(3):333-343. PubMed ID: 38018772
[TBL] [Abstract][Full Text] [Related]
2. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma.
Pan Y; Liu ZP; Dai HS; Chen WY; Luo Y; Wang YZ; Gao SY; Wang ZR; Dong JL; Liu YH; Yin XY; Liu XC; Fan HN; Bai J; Jiang Y; Cheng JJ; Zhang YQ; Chen ZY
World J Gastrointest Oncol; 2023 Jun; 15(6):1036-1050. PubMed ID: 37389112
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis of laparoscopic surgery and open surgery for hilar cholangiocarcinoma: a retrospective cohort study.
Yin Y; Tao J; Xian Y; Hu J; Li Y; Li Q; Xiong Y; He Y; He K; Li J
World J Surg Oncol; 2024 Feb; 22(1):58. PubMed ID: 38369496
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China.
Hu HJ; Jin YW; Shrestha A; Ma WJ; Wang JK; Liu F; Zhu YY; Zhou RX; Regmi P; Cheng NS; Li FY
Cancer Med; 2019 Apr; 8(4):1567-1575. PubMed ID: 30868740
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
6. Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery.
Xu ZL; Ou YJ; Dai HS; Wan K; Bie P; Chen ZY; Zhang LD; Zhang CC
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101695. PubMed ID: 34147661
[TBL] [Abstract][Full Text] [Related]
7. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
8. The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer.
Wang Z; Zhong Y; Zhou Y; Mao F; Zhang X; Wang C; Sun Q
Clin Interv Aging; 2023; 18():1163-1174. PubMed ID: 37525754
[TBL] [Abstract][Full Text] [Related]
9. The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy.
Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Kobayashi S; Ueno M; Morimoto M; Shiozawa M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S116-S121. PubMed ID: 33380664
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian Cancer.
Kahl A; du Bois A; Harter P; Prader S; Schneider S; Heitz F; Traut A; Alesina PF; Meier B; Walz M; Brueckner A; Groeben HT; Brunkhorst V; Heikaus S; Ataseven B
Ann Surg Oncol; 2017 Nov; 24(12):3692-3699. PubMed ID: 28871563
[TBL] [Abstract][Full Text] [Related]
11. [Robotic hilar cholangiocarcinoma radical resection compared with laparotomy in prognosis].
Chou S; Chang ZY; Zhao GD; Song DD; Zhang X; Hu MG; Liu R
Zhonghua Wai Ke Za Zhi; 2020 Mar; 58(3):230-234. PubMed ID: 32187928
[No Abstract] [Full Text] [Related]
12. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
[TBL] [Abstract][Full Text] [Related]
13. Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma.
Liu ZP; Chen WY; Zhang YQ; Jiang Y; Bai J; Pan Y; Zhong SY; Zhong YP; Chen ZY; Dai HS
World J Gastroenterol; 2022 Mar; 28(9):948-960. PubMed ID: 35317056
[TBL] [Abstract][Full Text] [Related]
14. [The clinical value of classification of hilar cholangiocarcinoma based on actual anatomy].
Peng SY; Liu YB; Li XS; Wu Y; Jin YQ; Yu XA; Wang W; Gong W
Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):860-865. PubMed ID: 36058713
[No Abstract] [Full Text] [Related]
15. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.
Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF
Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of nomogram model in evaluating the prognosis of cholangiocarcinoma after interventional therapy].
Li Z; Xie BC; Lyu PJ; Wang HX; Li Y; Wang CH; Li X; Ye SW; Li G; Pang PF; Zhang YY; Yu P
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1217-1224. PubMed ID: 37087405
[No Abstract] [Full Text] [Related]
17. [The effect of prealbumin on the long-term prognosis of hilar cholangiocarcinoma following radical surgery].
Chen ZY; Liu ZP; Dai HS; Jiang Y; He Y
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):378-386. PubMed ID: 35272430
[No Abstract] [Full Text] [Related]
18. Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.
Zhang CW; Liu J; Hong DF; Wang ZF; Hu ZM; Huang DS; Shang MJ; Yao WF
Surg Endosc; 2018 Mar; 32(3):1581-1582. PubMed ID: 28779241
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
[TBL] [Abstract][Full Text] [Related]
20. [The safety and effect of transhepatic hilar approach for the treatment of bismuth type Ⅲ and Ⅳ hilar cholangiocarcinoma].
He M; Wang HL; Yan JY; Xu SW; Chen W; Wang J
Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):360-366. PubMed ID: 29779312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
